Anesthetic considerations in the management of Wilms’ tumor

S. Whyte,J. Mark Ansermino
DOI: https://doi.org/10.1111/j.1460-9592.2006.01866.x
2006-05-01
Paediatric Anaesthesia
Abstract:Max Wilms, a German anatomist and surgeon, described a series of seven cases of nephroblastoma in 1899 (1). Although not the first to do so, his name has become eponymous with the malignancy. Just over a century later, the management of patients with Wilms’ tumor has developed into a multidisciplinary undertaking by surgeons, oncologists and pathologists, guided by the results of a series of national clinical trials in the US [National Wilms’ Tumor Study Group (NWTSG)], France [Société Internationale d’Oncologie Pédiatrique (SIOP)], the UK [UK Children’s Cancer Study Group (UKCCSG)], Germany, and Brazil. Anesthetists become involved in the care of these patients during imaging studies, primary or delayed surgical resection, and management of central venous access for chemotherapy administration. This review aims to provide an overview of current management of nephroblastoma and to address anesthesia implications of the disease and its treatment.
What problem does this paper attempt to address?